We are live on
!
Find out more
OFA
Oaktree Fund Advisors Portfolio holdings
AUM
$56.9M
1-Year Est. Return
80.32%
This Fund
S&P 500
This Quarter
Est. Return
+15.34%
1 Year Est. Return
+80.32%
3 Year Est. Return
+137.72%
5 Year Est. Return
+184.12%
10 Year Est. Return
–
AUM
$1.05M
AUM Growth
–
Cap. Flow
+$920K
Cap. Flow
% of AUM
87.54%
Top 10 Holdings %
Top 10 Hldgs %
91.06%
Holding
18
New
18
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
+$526K |
| 2 |
TSMC
TSM
|
+$73.9K |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$61.6K |
| 4 |
Vale
VALE
|
+$37.1K |
| 5 |
ICICI Bank
IBN
|
+$23.2K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.04% |
| 2 | Financials | 7.42% |
| 3 | Materials | 7.42% |
| 4 | Energy | 2.66% |
| 5 | Industrials | 1.24% |
Similar funds
LCM
CTFG
YEPI
DCI
2P
JRCM
EI
WCAU
Oaktree Fund Advisors's Q2 2021 Portfolio in Review
Q2 2021 is the first quarter with a 13F filing on record for Oaktree Fund Advisors, which disclosed 18 positions worth $1.05M. Its ten largest holdings account for 91% of the portfolio.
Its largest position is Sorrento Therapeutics, Inc.: 66,000 shares worth $640K.
By sector, the portfolio is most concentrated in Technology at 9% of assets, followed by Financials and Materials.
- Oaktree Fund Advisors's largest Q2 2021 buy was Sorrento Therapeutics, Inc.: 66,000 shares worth $640K.
- Oaktree Fund Advisors's ten largest holdings make up 91% of its $1.05M portfolio in Q2 2021.
- Oaktree Fund Advisors disclosed 18 positions in Q2 2021, its first 13F filing on record.
Based on Oaktree Fund Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.